Glass articles with low-friction coatings

US2017348192A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017348192-A1
Application numberUS-201715687059-A
CountryUS
Kind codeA1
Filing dateAug 25, 2017
Priority dateFeb 28, 2012
Publication dateDec 7, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Coated pharmaceutical packages are disclosed. The coated pharmaceutical packages may include a glass body comprising a first surface and a second surface opposite the first surface. The glass body may be a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container. A low-friction coating may be positioned on at least a portion of the first surface of the glass body. In embodiments, the low-friction coating may be a fluoropolymer.

First claim

Opening claim text (preview).

What is claimed is: 1 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a fluoropolymer. 2 . The coated pharmaceutical package of claim 1 , wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body; and a polymer layer positioned over the coupling agent layer, the polymer layer comprising the fluoropolymer. 3 . The coated pharmaceutical package of claim 1 , wherein the coupling agent layer comprises a silsesquioxane. 4 . The coated pharmaceutical package of claim 1 , wherein the low-friction coating has a coefficient of friction of less than or equal to 0.6. 5 . The coated pharmaceutical package of claim 1 , wherein a thickness of the low friction coating is less than or equal to 1 μm. 6 . The coated pharmaceutical package of claim 1 , wherein a thickness of the low friction coating is less than or equal to 100 nm. 7 . The coated pharmaceutical package of claim 1 , wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 8 . The coated pharmaceutical package of claim 1 , wherein a retained strength of the pharmaceutical package in horizontal compression does not decrease by more than about 20% after exposure to an elevated temperature of 260° C. for 30 minutes and abrasion under a 30 N load. 9 . The coated pharmaceutical package of claim 1 , wherein the portion of the exterior surface of the coated pharmaceutical package with the low-friction coating contains less than 6 glass checks per 5 mm length when abraded along a length of about 20 mm with a second coated borosilicate glass pharmaceutical package in a vial-on-vial testing jig under a normal load of 30 N and after exposing the coated glass pharmaceutical package and the second coated glass pharmaceutical package to a temperature of at least about 260° C. for 30 minutes. 10 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a fluoropolymer. 11 . The coated pharmaceutical package of claim 10 , wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body; and a polymer layer positioned over the coupling agent layer, the polymer layer comprising the fluoropolymer. 12 . The coated pharmaceutical package of claim 11 , wherein the coupling agent layer comprises a silsesquioxane. 13 . The coated pharmaceutical package of claim 10 , wherein the low-friction coating has a coefficient of friction of less than or equal to 0.6. 14 . The coated pharmaceutical package of claim 10 , wherein a thickness of the low friction coating is less than or equal to 1 μm. 15 . The coated pharmaceutical package of claim 10 , wherein a thickness of the low friction coating is less than or equal to 100 nm. 16 . The coated pharmaceutical package of claim 10 , wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 17 . The coated pharmaceutical package of claim 10 , wherein a retained strength of the pharmaceutical package in horizontal compression does not decrease by more than about 20% after exposure to an elevated temperature of 260° C. for 30 minutes and abrasion under a 30 N load. 18 . The coated pharmaceutical package of claim 10 , wherein the portion of the exterior surface of the coated pharmaceutical package with the low-friction coating contains less than 6 glass checks per 5 mm length when abraded along a length of about 20 mm with a second coated borosilicate glass pharmaceutical package in a vial-on-vial testing jig under a normal load of 30 N and after exposing the coated glass pharmaceutical package and the second coated glass pharmaceutical package to a temperature of at least about 260° C. for 30 minutes. 19 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a silsesquioxane-based polymer. 20 . The coated pharmaceutical package of claim 19 , wherein the low-friction coating has a coefficient of friction of less than or equal to 0.6. 21 . The coated pharmaceutical package of claim 19 , wherein a thickness of the low friction coating is less than or equal to 1 μm. 22 . The coated pharmaceutical package of claim 19 , wherein a thickness of the low friction coating is less than or equal to 100 nm. 23 . The coated pharmaceutical package of claim 19 , wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 24 . The coated pharmaceutical package of claim 19 , wherein a retained strength of the pharmaceutical package in horizontal compression does not decrease by more than about 20% after exposure to an elevated temperature of 260° C. for 30 minutes and abrasion under a 30 N load. 25 . The coated pharmaceutical package of claim 19 , wherein the portion of the exterior surface of the coated pharmaceutical package with the low-friction coating contains less than 6 glass checks per 5 mm length when abraded along a length of about 20 mm with a second coated borosilicate glass pharmaceutical package in a vial-on-vial testing jig under a normal load of 30 N and after exposing the coated glass pharmaceutical package and the second coated glass pharmaceutical package to a temperature of at least about 260° C. for 30 minutes. 26 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a silsesquioxane-based polymer. 27 . The coated pharmaceutical package of claim 26 , wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body; and a polymer layer positioned over the coupling agent layer, the polymer layer comprising the silsesquioxane-based polymer.

Assignees

Inventors

Classifications

  • Details; Accessories therefor (A61J7/00 takes precedence; openers B65D, B67B7/00) · CPC title

  • Coverings or external coatings (wrappers B65D65/00) · CPC title

  • Details of other kinds or types of rigid or semi-rigid containers · CPC title

  • Coating the outside · CPC title

  • with silicon-containing compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017348192A1 cover?
Coated pharmaceutical packages are disclosed. The coated pharmaceutical packages may include a glass body comprising a first surface and a second surface opposite the first surface. The glass body may be a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container. A low-friction coating may be positioned on at least a portio…
Who is the assignee on this patent?
Corning Inc
What technology area does this patent fall under?
Primary CPC classification A61J1/1468. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).